INDV
Indivior Pharmaceuticals Inc · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-26
Figures on this page computed 2026-11-08 12:32 UTC
Last close
36.28USD
Market data, 2026-11-02
Except where said otherwise: 10-K for 2025, filed 2026-02-26
21.6xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-26
396.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
16.9%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
-7.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-K for 2025, filed 2026-02-26
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
- 10-K for 2025, filed 2026-02-26
- 10-Q for 2025, filed 2026-10-29
n/aDividend yield
The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- Computed from the filing for 2016
Safety is the furthest below its sector's middle: 0.44 against 0.53 on the market's range.
- Growth13.9%82 of 100, above its sector
- Returns on capital396.9%98 of 100, above its sector
- Margins80.2%72 of 100, above its sector
- Price21.6x37 of 100, above its sector
- Safety0.7144 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aThe stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
Where the price sits
lens 6 of 9Its multiple of earnings
21.6x- Where it is now21.6x
- Its sector's middle26.9x
- The market's middle19.9x
Its own year, in the price it trades at
36.3Market data, 2026-11-02
Its price against earnings, set beside its own year, its sector and the market. A low multiple is cheap or it is broken, and this page does not claim to know which.
Its price against earnings, set beside its own year, its sector and the market. A low multiple is cheap or it is broken, and this page does not claim to know which.
Every figure in this lens
Price against earnings21.6x10-K for 2025, filed 2026-02-26
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-012237
- Reported in
- USD
Last close36.3Market data, 2026-11-02
- Source
- market
- Taken on
- 2026-11-02
- Reported in
- USD